| Payam Abrishami, MD | |
|
29525 Canwood St Ste 109, Agoura Hills, CA 91301-4230 | |
| (818) 338-7097 | |
| (818) 338-7099 |
| Full Name | Payam Abrishami |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 24 Years |
| Location | 29525 Canwood St Ste 109, Agoura Hills, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447288147 | NPI | - | NPPES |
| 00A866270 | Other | CA | MEDI CAL |
| P00729841 | Other | CA | RAILROAD MEDICARE |
| 00A866270 | Other | CA | BLUE SHIELD |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| J Robert West Md Inc | 8729990973 | 136 |
| Payam Abrishami, M.d., Inc. | 1355495813 | 2 |
News Archive
Altering the default order in which foods are shown on the screen, or offering substitutes lower in saturated fat could help customers make healthier choices when shopping for food online, according to a study published in the open access International Journal of Behavioral Nutrition and Physical Activity.
Results from a case control study show that coronary artery disease affecting the atrial branches is an independent predictor for new-onset atrial fibrillation (AF) after acute myocardial infarction (MI), or heart attack.
For a long time, scientists have dreamt of converting undesirable white fat cells into brown fat cells and thus simply have excess pounds melt away. Researchers at the University of Bonn have now gotten a step closer to this goal: They decoded a "toggle switch" in mice which can significantly stimulate fat burning.
Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
Amgen today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Kyprolis (carfilzomib) for Injection to seek an expanded indication for the treatment of patients with a form of blood cancer, relapsed multiple myeloma, who have received at least one prior therapy.
› Verified 1 days ago
| Entity Name | J Robert West Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932154788 PECOS PAC ID: 8729990973 Enrollment ID: O20031105000239 |
News Archive
Altering the default order in which foods are shown on the screen, or offering substitutes lower in saturated fat could help customers make healthier choices when shopping for food online, according to a study published in the open access International Journal of Behavioral Nutrition and Physical Activity.
Results from a case control study show that coronary artery disease affecting the atrial branches is an independent predictor for new-onset atrial fibrillation (AF) after acute myocardial infarction (MI), or heart attack.
For a long time, scientists have dreamt of converting undesirable white fat cells into brown fat cells and thus simply have excess pounds melt away. Researchers at the University of Bonn have now gotten a step closer to this goal: They decoded a "toggle switch" in mice which can significantly stimulate fat burning.
Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
Amgen today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Kyprolis (carfilzomib) for Injection to seek an expanded indication for the treatment of patients with a form of blood cancer, relapsed multiple myeloma, who have received at least one prior therapy.
› Verified 1 days ago
| Entity Name | Payam Abrishami, M.d., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205076502 PECOS PAC ID: 1355495813 Enrollment ID: O20090818000354 |
News Archive
Altering the default order in which foods are shown on the screen, or offering substitutes lower in saturated fat could help customers make healthier choices when shopping for food online, according to a study published in the open access International Journal of Behavioral Nutrition and Physical Activity.
Results from a case control study show that coronary artery disease affecting the atrial branches is an independent predictor for new-onset atrial fibrillation (AF) after acute myocardial infarction (MI), or heart attack.
For a long time, scientists have dreamt of converting undesirable white fat cells into brown fat cells and thus simply have excess pounds melt away. Researchers at the University of Bonn have now gotten a step closer to this goal: They decoded a "toggle switch" in mice which can significantly stimulate fat burning.
Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
Amgen today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Kyprolis (carfilzomib) for Injection to seek an expanded indication for the treatment of patients with a form of blood cancer, relapsed multiple myeloma, who have received at least one prior therapy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Payam Abrishami, MD 1010 Montego Dr, Los Angeles, CA 90049-1617 Ph: (818) 338-7097 | Payam Abrishami, MD 29525 Canwood St Ste 109, Agoura Hills, CA 91301-4230 Ph: (818) 338-7097 |
News Archive
Altering the default order in which foods are shown on the screen, or offering substitutes lower in saturated fat could help customers make healthier choices when shopping for food online, according to a study published in the open access International Journal of Behavioral Nutrition and Physical Activity.
Results from a case control study show that coronary artery disease affecting the atrial branches is an independent predictor for new-onset atrial fibrillation (AF) after acute myocardial infarction (MI), or heart attack.
For a long time, scientists have dreamt of converting undesirable white fat cells into brown fat cells and thus simply have excess pounds melt away. Researchers at the University of Bonn have now gotten a step closer to this goal: They decoded a "toggle switch" in mice which can significantly stimulate fat burning.
Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
Amgen today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Kyprolis (carfilzomib) for Injection to seek an expanded indication for the treatment of patients with a form of blood cancer, relapsed multiple myeloma, who have received at least one prior therapy.
› Verified 1 days ago
Bente H Berman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 29525 Canwood St, Suite 219, Agoura Hills, CA 91301 Phone: 818-865-8133 Fax: 818-865-1223 | |
Robert Stephen Dye, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 29525 Canwood St, Suite #219, Agoura Hills, CA 91301 Phone: 818-865-8133 Fax: 818-865-1223 |